• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer.

作者信息

Muto S, Horie S, Takahashi S, Tomita K, Kitamura T

机构信息

Department of Urology, Faculty of Medicine, The University of Tokyo, Japan.

出版信息

Cancer Res. 2000 Aug 1;60(15):4021-5.

PMID:10945601
Abstract

Mechanisms for multifocal bladder carcinogenesis remain unclear. To see whether normal mucosa had already acquired genetic or epigenetic changes, we examined loss of heterozygosity (LOH) at 10 microsatellite loci and methylation of the p16(INK4) CpG island in multiple tumors and pathologically normal mucosa in six patients with bladder cancer. Either LOH or methylation was detected in 77% of samples of normal epithelium, and LOH detected in samples of normal epithelium was also observed in most tumor samples. This result indicated that a population of cells in morphologically normal epithelium possessed genetic or epigenetic aberrations in common with bladder cancer, which might provide a ground for multiple tumorigenesis.

摘要

相似文献

1
Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer.
Cancer Res. 2000 Aug 1;60(15):4021-5.
2
Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time.在体内和体外,随着时间推移,人类膀胱癌基因组中的全局和基因特异性表观遗传模式相对稳定。
Cancer Res. 2001 Aug 1;61(15):5875-84.
3
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.膀胱癌患者尿沉渣中甲基化凋亡相关基因的检测
Clin Cancer Res. 2004 Nov 15;10(22):7457-65. doi: 10.1158/1078-0432.CCR-04-0930.
4
Clonal origin of lymph node metastases in bladder carcinoma.膀胱癌淋巴结转移的克隆起源
Cancer. 2005 Nov 1;104(9):1901-10. doi: 10.1002/cncr.21466.
5
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.膀胱癌患者组织学正常尿路上皮中9号染色体和8号染色体短臂的缺失
Eur Urol. 2005 Jan;47(1):58-63. doi: 10.1016/j.eururo.2004.07.012.
6
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.RASSF1A在人膀胱癌中频繁发生表观遗传失活。
Cancer Res. 2001 Sep 15;61(18):6688-92.
7
Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.P16表达缺失和9号染色体p21区域杂合性缺失在预测浅表性膀胱癌患者预后中的作用
J Surg Res. 2007 Dec;143(2):422-7. doi: 10.1016/j.jss.2007.01.012. Epub 2007 Jul 5.
8
Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.散发性结直肠癌及相应正常结肠黏膜中MGMT和p16基因的甲基化
Med Sci Monit. 2008 Oct;14(10):BR219-25.
9
Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.对16号染色体上与膀胱癌从隐匿性癌前病变发展到浸润性疾病相关的缺失区域进行遗传图谱绘制和基于DNA序列的分析。
Oncogene. 2001 Aug 16;20(36):5005-14. doi: 10.1038/sj.onc.1204612.
10
Molecular evidence supporting field effect in urothelial carcinogenesis.支持尿路上皮癌发生中场效应的分子证据。
Clin Cancer Res. 2005 Sep 15;11(18):6512-9. doi: 10.1158/1078-0432.CCR-05-0891.

引用本文的文献

1
Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer.长链非编码RNA软骨损伤相关分子促进膀胱癌的恶性进展。
Oncol Lett. 2018 Mar;15(3):3049-3055. doi: 10.3892/ol.2017.7678. Epub 2017 Dec 21.
2
Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes.膀胱癌中的分子生物标志物:预后和治疗结果的新型潜在指标
Dis Markers. 2016;2016:8205836. doi: 10.1155/2016/8205836. Epub 2016 Jan 26.
3
p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation.
p21与CK2相互作用介导的HDAC2磷酸化调节KLF4乙酰化以调控膀胱癌细胞增殖。
Tumour Biol. 2016 Jun;37(6):8293-304. doi: 10.1007/s13277-015-4618-1. Epub 2016 Jan 4.
4
Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study.膀胱癌患者和健康男性脱落尿路上皮细胞的染色体改变:一项前瞻性筛查研究。
BMC Cancer. 2014 Nov 20;14:854. doi: 10.1186/1471-2407-14-854.
5
Epigenetic markers for bladder cancer in urine.尿液中膀胱癌的表观遗传标志物。
Transl Oncogenomics. 2007 Mar 22;2:35-42. Print 2007.
6
Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.印度北部地区结直肠腺癌中 p16 的启动子异常甲基化。
World J Gastrointest Oncol. 2010 Jul 15;2(7):295-303. doi: 10.4251/wjgo.v2.i7.295.
7
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.表观遗传失调在砷毒性和致癌作用中的新作用。
Environ Health Perspect. 2011 Jan;119(1):11-9. doi: 10.1289/ehp.1002114. Epub 2010 Aug 2.
8
Hypermethylated SFRP1, but none of other nine genes "informative" for western countries, is valuable for bladder cancer detection in Mainland China.在中国大陆,高甲基化的SFRP1对膀胱癌检测有价值,但其他九个在西方国家“有参考价值”的基因则不然。
J Cancer Res Clin Oncol. 2009 Dec;135(12):1717-27. doi: 10.1007/s00432-009-0619-z. Epub 2009 Jun 30.
9
High throughput molecular diagnostics in bladder cancer - on the brink of clinical utility.膀胱癌的高通量分子诊断——迈向临床应用的边缘
Mol Oncol. 2008 Apr;1(4):384-94. doi: 10.1016/j.molonc.2007.11.002. Epub 2007 Dec 8.
10
Epigenetics in bladder cancer.膀胱癌中的表观遗传学
Int J Clin Oncol. 2008 Aug;13(4):298-307. doi: 10.1007/s10147-008-0811-1. Epub 2008 Aug 15.